CVS Health Corporation
CVS
$65.54
$1.963.08%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.61% | 8.21% | 1,789.66% | -95.08% | 59.03% |
| Total Depreciation and Amortization | 1.47% | 0.61% | -1.21% | 0.87% | 1.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.86% | 136.50% | -239.12% | 5,414.29% | 110.14% |
| Change in Net Operating Assets | -121.65% | 462.18% | 83.44% | -1,577.64% | -94.08% |
| Cash from Operations | -58.36% | 144.95% | 349.66% | -124.12% | -37.00% |
| Capital Expenditure | 18.30% | 3.26% | -14.63% | -5.02% | 9.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -495.00% | -100.00% | 16.67% | 75.00% | -92.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29,900.00% | -99.57% | 108.67% | -183.81% | 31.16% |
| Cash from Investing | -34.38% | -39.31% | 83.66% | -105.97% | 22.40% |
| Total Debt Issued | -- | -- | 612.17% | -75.41% | -3.14% |
| Total Debt Repaid | 152.43% | 47.77% | -108.78% | -570.78% | -1,116.67% |
| Issuance of Common Stock | -67.36% | 657.89% | -83.33% | 356.00% | -87.68% |
| Repurchase of Common Stock | -936.36% | -175.00% | 0.00% | 97.18% | 95.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.10% | -0.24% | -0.12% | 2.45% | -2.14% |
| Other Financing Activities | 4.35% | -147.92% | 500.00% | 166.67% | 109.09% |
| Cash from Financing | 134.56% | -641.07% | 127.14% | -227.14% | 201.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.84% | -16.17% | 130.70% | -309.36% | 71.49% |